Tilray is a drug manufacturers-specialty & generic business based in Canada. Tilray stocks (APHA.TO) are listed on the TO and all prices are listed in Canadian Dollars. Tilray employs 1,200 staff and has a trailing 12-month revenue of around C$611.1 million.
How to buy Tilray stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: APHA in this case.
- Research Tilray stocks. The platform should provide the latest information available.
- Buy your Tilray stocks. It's that simple.
Tilray stock priceUse our graph to track the performance of APHA stocks over time.
Tilray stocks at a glance
|Latest market close||C$N/A|
|52-week range||C$5.58 - C$30.7|
|50-day moving average||C$21.7961|
|200-day moving average||C$19.2083|
|Wall St. target price||C$18.54|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||C$0.116|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Tilray stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Tilray under- or over-valued?
Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tilray's EBITDA (earnings before interest, taxes, depreciation and amortisation) is CADC$9 million.
The EBITDA is a measure of a Tilray's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||CADC$611.1 million|
|Gross profit TTM||CADC$191 million|
|Return on assets TTM||-1.31%|
|Return on equity TTM||-34.14%|
|Market capitalisation||CADC$4.4 billion|
TTM: trailing 12 months
How to short and sell Tilray stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "APHA.TO"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 12.0 million Tilray stocks held short by investors – that's known as Tilray's "short interest". This figure is 41.7% up from 8.4 million last month.
There are a few different ways that this level of interest in shorting Tilray stocks can be evaluated.
Tilray's "short interest ratio" (SIR)
Tilray's "short interest ratio" (SIR) is the quantity of Tilray stocks currently shorted divided by the average quantity of Tilray stocks traded daily (recently around 3.4 million). Tilray's SIR currently stands at 3.52. In other words for every 100,000 Tilray stocks traded daily on the market, roughly 3520 stocks are currently held short.
However Tilray's short interest can also be evaluated against the total number of Tilray stocks, or, against the total number of tradable Tilray stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.05% of the outstanding stocks (for every 100,000 Tilray stocks in existence, roughly 50 stocks are currently held short) or 0% of the tradable stocks (for every 100,000 tradable Tilray stocks, roughly 0 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Tilray.
Find out more about how you can short Tilray stock.
Tilray stock dividends
We're not expecting Tilray to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Tilray stocks ever split?
Tilray stocks were split on a 1:10 basis on 8 December 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tilray stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Tilray stocks which in turn could have impacted Tilray's stock price.
Tilray stock price volatility
Over the last 12 months, Tilray's stocks have ranged in value from as little as C$5.58 up to C$30.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while Tilray's is 2.6198. This would suggest that Tilray's stocks are significantly more volatile than the average for this exchange and represent a higher risk.
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Stocks similar to Tilray
Tilray in the news
Frequently asked questions
More guides on Finder
How to buy Zevia PBC (ZVIA) stock in Canada
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
How to buy Xponential Fitness (XPOF) stock in Canada when it goes public
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
How to buy SOPHiA Genetics (SOPH) stock in Canada when it goes public
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
How to buy Ryan Specialty Group Holdings (RYAN) stock in Canada
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
How to buy Ocean Biomedical (OCEA) stock in Canada when it goes public
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
How to buy Instructure Holdings (INST) stock in Canada
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
How to buy Gambling.com Group (GAMB) stock in Canada when it goes public
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
How to buy Elicio Therapeutics (ELTX) stock in Canada when it goes public
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
How to buy Cytek Biosciences (CTKB) stock in Canada when it goes public
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
How to buy Core & Main (CNM) stock in Canada when it goes public
Everything we know about the Core & Main IPO, plus information on how to buy in.